insights_auto
Why is SYRE up 7.53%?
Dive Deeperchevron_right
SYRE:NASDAQ
Spyre Therapeutics Inc
$103.86
arrow_upward
+7.53%(+7.27) 1D
$103.00
arrow_downward
-0.83% (-0.86)bedtimeAfter hours
Closed: Nov 6, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SYRE...
Open
$98.35
High
$104.30
Low
$97.29
Mkt. cap
9.86B
Avg. vol.
1.28M
Volume
1.64M
52-wk high
$110.18
52-wk low
$21.14
EPS
-$3.22
Beta
3.24
Shares outstanding
94.97M
No. of employees
130
Open
$98.35
High
$104.30
Low
$97.29
Mkt. cap
9.86B
Avg. vol.
1.28M
Volume
1.64M
52-wk high
$110.18
52-wk low
$21.14
EPS
-$3.22
Beta
3.24
Shares outstanding
94.97M
No. of employees
130
News stories
From web sources and news partners
TheStreet
·
32 minutes ago
Why S&P 500 investors may want to look beyond mega-cap tech
Binance
·
1 hour ago
TradFi News | Nasdaq Drops 3.4% in Week as AI Chip Stocks Slump; Berkshire Posts Record $9.6 Billion Buyback
IndexBox
·
1 hour ago
Capital Economics Warns AI Investment Boom Is Fading, Sees S&P 500 Falling 12% by End of 2027
Yahoo Finance
·
5 hours ago
Coca-Cola (KO) Makes the Dow’s Low-Upside List While Selling More Drinks, Not Just Charging More
About Spyre Therapeutics Inc
CEO-
Employees130
FoundedJan 1, 2013
HeadquartersWaltham, Massachusetts, United States
SectorHealth Care
IndustryBiotechnology
Websitespyre.com